Stock Research: Masimo

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Masimo

NasdaqGS:MASI US5747951003
29
  • Value
    27
  • Growth
    63
  • Safety
    Safety
    18
  • Combined
    18
  • Sentiment
    59
  • 360° View
    360° View
    29
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Masimo Corporation develops, manufactures, and markets patient monitoring technologies and automation solutions. It operates in healthcare and non-healthcare segments, with products including monitors, sensors, and software. The company's healthcare products are sold to hospitals and other healthcare providers. Its non-healthcare business includes audio and home integration technologies. In the last fiscal year, the company had a market cap of $8,704 million, profits of $1,004 million, and revenue of $2,094 million with 3600 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 29 (better than 29% compared with alternatives), overall professional sentiment and financial characteristics for the stock Masimo are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Masimo. The consolidated Growth Rank has a good rank of 63, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 63% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 59, which means that professional investors are more optimistic about the stock than for 59% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 18, which means that the share price of Masimo is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 82% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 27, which means that the company has a financing structure that is riskier than those of 73% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
D.J. US Medical Equipment
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
18 25 34 19
Growth
63 77 31 27
Safety
Safety
27 28 34 98
Sentiment
59 37 34 74
360° View
360° View
29 31 1 62
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
72 65 47 20
Opinions Change
93 50 50 50
Pro Holdings
n/a 58 51 78
Market Pulse
44 29 26 77
Sentiment
59 37 34 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
18 25 34 19
Growth
63 77 31 27
Safety Safety
27 28 34 98
Combined
18 34 15 38
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
37 20 19 21
Price vs. Earnings (P/E)
24 38 56 23
Price vs. Book (P/B)
19 37 44 43
Dividend Yield
1 1 1 1
Value
18 25 34 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
37 12 10 35
Profit Growth
84 78 15 37
Capital Growth
37 86 93 47
Stock Returns
55 77 45 55
Growth
63 77 31 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
38 44 30 100
Refinancing
29 16 27 31
Liquidity
45 66 76 98
Safety Safety
27 28 34 98

Similar Stocks

Discover high‑ranked alternatives to Masimo and broaden your portfolio horizons.

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.